Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk
Condition: Osteoporosis and Cardio-Metabolic Syndrome Following Spinal Cord Injury Interventions: Drug: Rosuvastatin Calcium; Drug: Placebo Oral Tablet; Dietary Supplement: Coenzyme Q10; Dietary Supplement: Calcium Carbonate; Dietary Supplement: Vitamin D Sponsors: Dr. B. Catharine. Craven; The Craig H. Neilsen Foundation; Toronto Rehabilitation Institute; University Health Network, Toronto; University of Miami Not yet recruiting - verified April 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Calcium | Cardiology | Cholesterol | Heart | Metabolic Syndrome | Nutrition | Orthopaedics | Osteoporosis | Rehabilitation | Spinal Cord Injury | Statin Therapy